A novel neutrophil extracellular trap signature to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma

Head and neck squamous cell carcinoma (HNSCC) is one of the most common malignant cancers, and patients with HNSCC possess early metastases and poor prognosis. Systematic therapies (including chemotherapy, targeted therapy, and immunotherapy) are generally applied in the advanced/late stages of HNSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qilin, Chen, Weimin, Li, Qiuhui, Mao, Jing, Chen, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549764/
https://www.ncbi.nlm.nih.gov/pubmed/36225931
http://dx.doi.org/10.3389/fimmu.2022.1019967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549764/
https://www.ncbi.nlm.nih.gov/pubmed/36225931
http://dx.doi.org/10.3389/fimmu.2022.1019967

Ejemplares similares